1887

Abstract

Summary: The class 3 outer-membrane protein (OMP) of is a potential target for bactericidal and opsonic antibodies in humans. Synthetic peptides spanning the class 3 OMP from the vaccine strain 44/76 (B: 15:P1.7,16:L3,7) were synthesized on pins and screened with serum obtained from Norwegian adolescents immunized with a meningococcal serogroup B outer-membrane vesicle (OMV) vaccine. A strong IgG response to a single peptide (FHQNGQVTEVTT) located within loop 1 (VR1) was stimulated after three doses of OMV vaccine in three vaccinees selected on the basis of their antibody response to class 3 OMP. No clear linear B-cell epitopes were recognized by four different murine serotype 15-specific mAbs. A 23mer peptide (D63b2) containing loop 1 of the class 3 OMP was synthesized, and the IgG responses were measured in pre- and post-vaccination serum from 27 vaccinees. Specific IgG rose significantly in 37% of vaccinees 6 weeks after the second dose and in 74% of the vaccinees 6 weeks after the third dose of the OMV vaccine. Most immune sera reacted distinctly on immunoblots with denatured class 3 OMP, and the immunoblotting reactivity correlated strongly with concentration of the IgG antibodies specific for peptide D63b2. When added to a post-vaccination serum from one vaccinee, peptide D63b2 competed efficiently with the class 3 OMP for specific antibody binding on immunoblots and in pin ELISA. The results show that the significant part of the humoral response to the meningococcal class 3 OMP elicited by vaccination with the Norwegian OMV vaccine was directed against a single continuous epitope.

Loading

Article metrics loading...

/content/journal/micro/10.1099/13500872-141-7-1593
1995-07-01
2022-01-28
Loading full text...

Full text loading...

/deliver/fulltext/micro/141/7/mic-141-7-1593.html?itemId=/content/journal/micro/10.1099/13500872-141-7-1593&mimeType=html&fmt=ahah

References

  1. Abdillahi H. 1988; Monoclonal antibodies and Neisseria meningitidis. Typing and subtyping for epidemiological surveillance and vaccine development.. Netherlands: State University of Utrecht;
    [Google Scholar]
  2. Abdillahi H., Poolman J.T. 1987; Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies.. FEMS Microbiol Lett 48:367–371
    [Google Scholar]
  3. Bjune G., Closs O., Frøholm L.O., Grønnesby J.K., Høiby E.A., Nøkleby H. 1991a; Design of clinical trials with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway.. NIPH Ann 14:81–93
    [Google Scholar]
  4. Bjune G., Høiby E.A., Grønnesby J.K., Arnesen O., Fredriksen J.H., Halstensen A., Holten E., Lindbak A.-K., Nøkleby H., Rosenqvist E., Solberg L.K., Closs O., Eng J., Frøholm L.O., Lystad A., Bakketeig L.S., Hareide B. 1991b; Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway.. Lancet 338:1093–1096
    [Google Scholar]
  5. Butcher S., Sarvas M., Runeberg-Nyman K. 1991; Class-3 porin protein of Neisseria meningitidis: cloning and structure of the gene.. Gene 105:125–128
    [Google Scholar]
  6. Chicz R.M., Urban R.G. 1994; Analysis of MHC-presented peptides: applications in autoimmunity and vaccine development.. Immunol Today 15:155–160
    [Google Scholar]
  7. Chicz R.M., Urban R.G., Lane W.S., Gorga J.C., Stern L.J., Vignali D.A.A., Strominger J.L. 1992; Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.. Nature 358:764–768
    [Google Scholar]
  8. Christodoulides M., Heckels J.E. 1994; Immunization with a multiple antigen peptide containing defined B- and T-cell epitopes: production of bactericidal antibodies against group B Neisseria meningitidis.. Microbiology 140:2951–2960
    [Google Scholar]
  9. Christodoulides M., McGuinness B.T., Heckels J.E. 1993; Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide.. J Gen Microbiol 139:1729–1738
    [Google Scholar]
  10. de Cossio M.E.F., Ohlin M., Llano M., Selander B., Cruz S., delValle J., Borrebaeck C.A.K. 1992; Human monoclonal antibodies against an epitope on the class 5c outer membrane protein common to many pathogenic strains of Neisseria meningitidis.. J Infect Dis 166:1322–1328
    [Google Scholar]
  11. Delvig A., Jahn S., Kusecek B., Heckels J.E., Rosenqvist E., Høiby E.A., Michaelsen T., Achtman M. 1994; A comparison of human and murine monoclonal IgGs specific for the P1.7 PorA protein of Neisseria meningitidis.. Mol Immunol 31:1257–1267
    [Google Scholar]
  12. Feavers I.M., Suker J., McKenna A.J., Heath A.B., Maiden M.C.J. 1992; Molecular analysis of the serotyping antigens of Neisseria meningitidis.. Infect Immun 60:3620–3629
    [Google Scholar]
  13. Frasch C.E., Zollinger W.D., Poolman J.T. 1985; Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.. Rev Infect Dis 7:504–510
    [Google Scholar]
  14. Fredriksen J.H., Rosenqvist E., Wedege E., Bryn K., Bjune G., Frøholm L.O., Lindbak A.-K., Møgster B., Namork E., Rye U., Stabbetorp G., Winsnes R., Aase B., Closs O. 1991; Production, characterization and control of MenB-vaccine ‘ Folkehelsa ’: an outer membrane vesicle vaccine against group B meningococcal disease.. NIPH Ann 14:67–79
    [Google Scholar]
  15. Guttormsen H.-K., Bjerknes R., Halstensen A., Naess A., Høiby E. A., Solberg C. O. 1993a; Cross-reacting serum opsonins to meningococci after vaccination.. J Infect Dis 167:1314–1319
    [Google Scholar]
  16. Guttormsen H.-K., Wetzler L. M., Naess A. 1993b; Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease.. Infect Immun 61:4734–4742
    [Google Scholar]
  17. Harthug S., Rosenqvist E., Høiby E.A., Gedde-Dahl T.W., Frøholm L.O. 1986; Antibody response in group B meningococcal disease determined by enzyme-linked immunosorbent assay with serotype 15 outer membrane antigen.. J Clin Microbiol 24:947–953
    [Google Scholar]
  18. Hitchcock P.J. 1989; Unified nomenclature for pathogenic Neisseria species.. Clin Microbiol Rev 2: (Suppl.) S64–S65
    [Google Scholar]
  19. Hobbs M.M., Seiler A., Achtman M., Cannon J.G. 1994; Microevolution within a clonal population of pathogenic bacteria: recombination, gene duplication and horizontal genetic exchange in the opa gene family of Neisseria meningitidis.. Mol Microbiol 12:171–180
    [Google Scholar]
  20. Holten E. 1979; Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978.. J Clin Microbiol 9:186–188
    [Google Scholar]
  21. Kapperud G., Nesbakken T., Aleksic S., Mollaret H.H. 1990; Comparison of restriction endonuclease analysis and phenotypic typing methods for differentiation of Yersinia enterocolica isolates.. J Clin Microbiol 28:1125–1131
    [Google Scholar]
  22. Laver W.G., Air G.M., Webster R.G., Smith-Gill S.J. 1990; Epitopes on protein antigens: misconceptions and realities.. Cell 61:553–556
    [Google Scholar]
  23. van der Ley P., Heckels J.E., Virji M., Hoogerhout P., Poolman J.T. 1991; Topology of outer membrane porins in pathogenic Neisseria spp.. Infect lmmun 59:2963–2971
    [Google Scholar]
  24. McGuinness B.T., Barlow A.K., Clarke I.N., Farley J.E., Anilionis A., Poolman J.T., Heckels J.E. 1990; Deduced amino acid sequences of class 1 protein (Por A) from three strains of Neisseria meningitidis. Synthetic peptides define the epitopes responsible for serosubtype specificity.. J Exp Med 171:1871–1882
    [Google Scholar]
  25. McGuinness B.T., Lambden P.R., Heckels J.E. 1993; Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology.. Mol Microbiol 1:505–514
    [Google Scholar]
  26. Maiden M.C.J., Suker J., McKenna A.J., Bygraves J.A., Feavers I.M. 1991; Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidis.. Mol Microbiol 5:727–736
    [Google Scholar]
  27. Matsushita S., Takahashi K., Motoki M., Komoriya K., Ikagawa S., Nishimura Y. 1994; Allele specificity of structural requirements for peptide bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.. J Exp Med 180:873–883
    [Google Scholar]
  28. Morelli G., del Valle J., Lammel C.J., Pohlner J., Müller K., Blake M., Brooks G.F, Meyer , Koumaré B., Brieske N., Achtman M. 1994; Immunogenicity and evolutionary variability of epitopes within IgAl protease from serogroup A Neisseria meningitidis.. Mol Microbiol 11:175–187
    [Google Scholar]
  29. Mutter M., Vuilleumier S. 1989; A chemical approach to protein design - template-assembled synthetic proteins (TASP).. Angew Chem Int Ed Engl 28:535–554
    [Google Scholar]
  30. Plikaytis B.D., Turner S.H., Gheesling L.L., Carlone G.M. 1991; Comparisons of standard curve fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay (ELISA).. J Clin Microbiol 29:1439–1446
    [Google Scholar]
  31. Rosenqvist E., Høiby E. A., Wedege E., Caugant D. A., Frøholm L.O., McGuinness B. T., Brooks J., Lambden P. R., Heckels J. E. 1993a; A new variant of serosubtype P1. 16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine.. Microb Pathog 15:197–205
    [Google Scholar]
  32. Rosenqvist E., Høiby E. A., Wedege E., Kusecek B., Achtman M. 1993b; The 5C protein of Neisseria meningitidis is highly immunogenic in humans and stimulates bactericidal antibodies.. J Infect Dis 167:1065–1073
    [Google Scholar]
  33. Saukkonen K., Abdillahi H., Poolman J.T., Leinonen M. 1987; Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B: 15: P1. 16 in infant rat infection model: new prospects for vaccine development.. Microb Pathog 3:261–267
    [Google Scholar]
  34. Spurkland A., Rønningen K.S., Leivestad T., Vartdal F., Thorsby E. 1992; HLA-DR-DQ haplotype frequencies in a Norwegian population.. Transplant Proc 24:298–299
    [Google Scholar]
  35. Thompson S.A., Wang L.L., West A., Sparling P.F. 1993; Neisseria meningitidis produces iron-regulated proteins related to the RTX family of exoproteins.. J Bacteriol 175:811–818
    [Google Scholar]
  36. Tinsley C.R., Virji M., Heckels J.E. 1992; Antibodies recognizing a variety of different structural motifs on meningococcal Lip antigen fail to demonstrate bactericidal activity.. J Gen Microbiol 138:2321–2328
    [Google Scholar]
  37. Vedros N. A. 1987 Evolution of Meningococcal Disease 1 Boca Raton, FL: CRC Press;
    [Google Scholar]
  38. Vignali D.A.A., Strominger J.L. 1994; Coreceptor function and the characteristics of MHC-bound peptides. A common link?. The Immunologist 2:112–118
    [Google Scholar]
  39. Virji M., Heckels J.E. 1989; Location of a blocking epitope on outer-membrane protein III of Neisseria gonorrhoeae by synthetic peptide analysis.. J Gen Microbiol 135:1895–1899
    [Google Scholar]
  40. Virji M., Heckels J.E., Potts W.J., Hart C.A., Saunders J.R. 1989; Identification of epitopes recognized by monoclonal antibodies SMI and SM2 which react with all pili of Neisseria gonorrhoeae but which differentiate between two structural classes of pili expressed by Neisseria meningitidis and the distribution of their encoding sequences in the genomes of Neisseria spp.. J Gen Microbiol 135:3239–3251
    [Google Scholar]
  41. Ward M.J., Lambden P.R., Heckels J.E. 1992; Sequence analysis and relationships between meningococcal class 3 serotype proteins and other porins from pathogenic and non-pathogenic Neisseria species.. FEMS Microbiol Lett 73:283–289
    [Google Scholar]
  42. Wedege E., Bryn K., Frøholm L.O. 1988; Restoration of antibody binding to blotted meningococcal outer membrane proteins using various detergents.. J Immunol Methods 113:51–59
    [Google Scholar]
  43. Wedege E., Bjune G., Frøholm L.O., Høiby E.A., Rosenqvist E. 1991; Immunoblotting studies of vaccinee and patient sera from the Norwegian serogroup B meningococcal vaccination trial.. NIPH Ann 14:183–187
    [Google Scholar]
  44. Wedege E., Dalseg R., Caugant D.A., Poolman J.T., Frøholm L.O. 1993; Expression of an inaccessible PI.7 subtype epitope on meningococcal class 1 proteins.. J Med Microbiol 38:23–28
    [Google Scholar]
  45. Wiertz E.J.H.J., Van Gaans-van den Brink J.A.M., Gausepohl H., Prochnicka-Chalufour A., Hoogerhout P., Poolman J.T. 1992; Identification of T cell epitopes occurring in a meningococcal class 1 outer membrane protein using overlapping peptides assembled with simultaneous multiple peptide synthesis.. J Exp Med 176:79–86
    [Google Scholar]
  46. Wolff K., Stern A. 1991; The class 3 outer membrane protein (PorB) of Neisseria meningitidis: gene sequence and homology to the gonococcal porin PI A.. FEMS Microbiol Lett 83:179–186
    [Google Scholar]
  47. Zapata G.A., Vann W.F., Rubinstein Y., Frasch C.E. 1992; Identification of variable region differences in Neisseria meningitidis class 3 protein sequences among five group B serotypes.. Mol Microbiol 6:3493–3499
    [Google Scholar]
  48. Zollinger W.D., Moran E.E., Connelly H., Mandrell R.E., Brandt B. 1984; Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins of Neisseria meningitidis and their use in serotyping.. Infect lmmun 46:260–266
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/micro/10.1099/13500872-141-7-1593
Loading
/content/journal/micro/10.1099/13500872-141-7-1593
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error